NCT04616976View on ClinicalTrials.gov

COVID-19 With Convalescent Plasma

CompletedOBSERVATIONAL
Enrollment

78

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

February 29, 2020

Study Completion Date

November 1, 2020

Conditions
COVID-19 Convalescent Plasma Treatment
Interventions
BIOLOGICAL

convalescent plasma

convalescent plasma was get from the patients who recovery from COVID-19

Trial Locations (1)

210009

Zhongda Hospital, Southeast University, Nanjing

All Listed Sponsors
lead

Southeast University, China

OTHER

NCT04616976 - COVID-19 With Convalescent Plasma | Biotech Hunter | Biotech Hunter